Patel A, Yang H, Douglas RS (2019) A new era in the treatment of thyroid eye disease. Am J Ophthalmol 208:281–288
Article CAS PubMed Google Scholar
Wang Y, Padnick-Silver L, Francis-Sedlak M, Holt RJ, Foley C, Douglas RS (2022) Inflammatory and noninflammatory thyroid eye disease: comparison of disease signs, symptoms, and quality of life in patients in the United States. Endocr Pract 28(9):842–846
Otto EA, Ochs K, Hansen C, Wall JR, Kahaly GJ (1996) Orbital tissue-derived T lymphocytes from patients with Graves’ ophthalmopathy recognize autologous orbital antigens. J Clin Endocrinol Metab 81(8):3045–3050
Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R (1989) Clinical criteria for the assessment of disease activity in Graves’ ophthalmopathy: a novel approach. Br J Ophthalmol 73(8):639–644
Article CAS PubMed PubMed Central Google Scholar
Gontarz-Nowak K, Szychlińska M, Matuszewski W, Stefanowicz-Rutkowska M, Bandurska-Stankiewicz E (2020) Current knowledge on graves' orbitopathy. J Clin Med. 10(1).
Bahn RS (2010) Graves’ ophthalmopathy. N Engl J Med 362(8):726–738
Article CAS PubMed PubMed Central Google Scholar
Tsui S, Naik V, Hoa N, Hwang CJ, Afifiyan NF, Sinha Hikim A et al (2008) Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves’ disease. J Immunol 181(6):4397–4405
Article CAS PubMed Google Scholar
Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R et al (2020) Teprotumumab for the treatment of active thyroid eye disease. N Engl J Med 382(4):341–352
Article CAS PubMed Google Scholar
Ugradar S, Kang J, Kossler AL, Zimmerman E, Braun J, Harrison AR et al (2022) Teprotumumab for the treatment of chronic thyroid eye disease. Eye (Lond) 36(8):1553–1559
Article CAS PubMed Google Scholar
Denisova K, Barmettler A (2021) Evaluating the thyroid eye disease patient. Int Ophthalmol Clin 61(2):33–52
Barbesino G, Salvi M, Freitag SK (2022) Future projections in thyroid eye disease. J Clin Endocrinol Metab 107(Suppl_1):S47–S56.
Article PubMed PubMed Central Google Scholar
Smith TJ, Kahaly GJ, Ezra DG, Fleming JC, Dailey RA, Tang RA et al (2017) Teprotumumab for thyroid-associated ophthalmopathy. N Engl J Med 376(18):1748–1761
Article CAS PubMed PubMed Central Google Scholar
Ma L, Hui S, Li Y, Hou Z, Liu Z, Chang Q et al (2022) Different characteristics of orbital soft tissue expansion in graves orbitopathy: extraocular muscle expansion is correlated to disease activity while fat tissue volume with duration. J Craniofac Surg 33(8):2354–2359
Li Q, Ye H, Ding Y, Chen G, Liu Z, Xu J et al (2017) Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases. PLoS ONE 12(5):e0176064
Article PubMed PubMed Central Google Scholar
Van Dyk HJ (1981) Orbital Graves' disease. A modification of the "NO SPECS" classification. Ophthalmology 88(6):479–483.
Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, Marcocci C et al (2021) The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy. Eur J Endocrinol 185(4):G43–G67
Article CAS PubMed Google Scholar
Dolman PJ (2018) Grading severity and activity in thyroid eye disease. Ophthalmic Plast Reconstr Surg 34(4S Suppl 1):S34–S40.
Mourits MP, Prummel MF, Wiersinga WM, Koornneef L (1997) Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin Endocrinol (Oxf) 47(1):9–14
Article CAS PubMed Google Scholar
Rundle FF, Wilson CW (1945) Development and course of exophthalmos and ophthalmoplegia in Graves’ disease with special reference to the effect of thyroidectomy. Clin Sci 5(3–4):177–194
Perros P, Baldeschi L, Boboridis K, Dickinson AJ, Hullo A, Kahaly GJ et al (2006) A questionnaire survey on the management of Graves’ orbitopathy in Europe. Eur J Endocrinol 155(2):207–211
Article CAS PubMed Google Scholar
Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C et al (2008) Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158(3):273–285
Article CAS PubMed Google Scholar
Dolman PJ, Cahill K, Czyz CN, Douglas RS, Elner VM, Feldon S et al (2012) Reliability of estimating ductions in thyroid eye disease: an International Thyroid Eye Disease Society multicenter study. Ophthalmology 119(2):382–389
Dickinson AJ, Perros P (2001) Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. Clin Endocrinol (Oxf) 55(3):283–303
Article CAS PubMed Google Scholar
Wiersinga WM, Perros P, Kahaly GJ, Mourits MP, Baldeschi L, Boboridis K et al (2006) Clinical assessment of patients with Graves’ orbitopathy: the European Group on Graves’ Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol 155(3):387–389
Article CAS PubMed Google Scholar
Dagi LR, Zoumalan CI, Konrad H, Trokel SL, Kazim M (2011) Correlation between extraocular muscle size and motility restriction in thyroid eye disease. Ophthalmic Plast Reconstr Surg 27(2):102–110
Bontzos G, Papadaki E, Mazonakis M, Maris TG, Tsakalis NG, Drakonaki EE et al (2022) Extraocular muscle volumetry for assessment of thyroid eye disease. J Neuroophthalmol 42(1):e274–e280
Dolman PJ, Rootman J (2006) VISA classification for graves orbitopathy. Ophthalmic Plast Reconstr Surg 22(5):319–324
Dolman PJ (2012) Evaluating Graves’ orbitopathy. Best practice and research. Clin Endocrinol Metabolism 26:229–248.
Hutchings KR, Fritzhand SJ, Esmaeli B, Koka K, Zhao J, Ahmed S, et al (2023) Graves' Eye disease: clinical and radiological diagnosis. Biomedicines 11(2).
Mawn LA, Dolman PJ, Kazim M, Strianese D, Genol I, Chong KKL et al (2018) Soft tissue metrics in thyroid eye disease: an international thyroid eye disease society reliability study. Ophthalmic Plast Reconstr Surg 34(6):544–546
Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15(2):155–163
Article PubMed PubMed Central Google Scholar
Bartko JJ (1966) The intraclass correlation coefficient as a measure of reliability. Psychol Rep 19(1):3–11
Article CAS PubMed Google Scholar
Schuck P (2004) Assessing reproducibility for interval data in health-related quality of life questionnaires: which coefficient should be used? Qual Life Res 13(3):571–586
Article ADS PubMed Google Scholar
Liljequist D, Elfving B, Skavberg RK (2019) Intraclass correlation—a discussion and demonstration of basic features. PLoS ONE 14(7):e0219854
Article CAS PubMed PubMed Central Google Scholar
Li L, Zeng L, Lin ZJ, Cazzell M, Liu H (2015) Tutorial on use of intraclass correlation coefficients for assessing intertest reliability and its application in functional near-infrared spectroscopy-based brain imaging. J Biomed Opt 20(5):50801
Edwards DT, Bartley GB, Hodge DO, Gorman CA, Bradley EA (2004) Eyelid position measurement in Graves’ ophthalmopathy: reliability of a photographic technique and comparison with a clinical technique. Ophthalmology 111(5):1029–1034
Hunt RJ (1986) Percent agreement, Pearson’s correlation, and kappa as measures of inter-examiner reliability. J Dent Res 65(2):128–130
Article MathSciNet CAS PubMed Google Scholar
McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 22(3):276–282
Article MathSciNet PubMed Google Scholar
Karlin J, Gai L, LaPierre N, Danesh K, Farajzadeh J, Palileo B, Taraszka K, Zheng J, Wang W, Eskin E, Rootman D (2022) Ensemble neural network model for detecting thyroid eye disease using external photographs. Br J Ophthalmol. https://doi.org/10.1136/bjo-2022-321833
Moon JH, Shin K, Lee GM, Park J, Lee MJ, Choung H et al (2022) Machine learning-assisted system using digital facial images to predict the clinical activity score in thyroid-associated orbitopathy. Sci Rep 12(1):22085
Comments (0)